Planet 13 Receives Exemption for Filing Restated Interim Financial Reports

3 years ago

LAS VEGAS, NV / ACCESSWIRE / March 28, 2022 / Pursuant to subsection 4.3(4) of National Instrument 51-102, in connection…

Pear Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

3 years ago

$4.2 million total revenue for the full year 2021 2021 highlights include Current Procedural Terminology (CPT) codes for prescribers, first…

Andau Medical Inc. Signs Exclusive Canadian Distribution Agreement with Mercury Medical for Airtraq Effective March 17, 2022

3 years ago

Mercury Medical Has Selected Andau Medical As Their Canadian Airtraq Video Laryngoscope System Distribution Partner With the Signing of an…

Planet 13 Announces Q4 and Full Year 2021 Financial Results

3 years ago

Q4 2021 revenue of $29.9 million, up 48% compared to Q4 2020Q4 2021 net loss of $5.1 million, compared to…

TRxADE HEALTH Reports Year End 2021 Financial Results

3 years ago

Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / March 28, 2022 / TRxADE HEALTH,…

NeoGenomics Announces CEO Departure and Initiates CEO Search

3 years ago

Board Appoints Executive Chair and Interim Office of the CEOAnticipates First Quarter Results Below Guidance and Withdraws 2022 GuidanceFT. MYERS,…

Former Deputy OPP Commissioner Becomes NCACT Executive Director

3 years ago

Toronto, Ontario--(Newsfile Corp. - March 28, 2022) - The National Coalition Against Contraband Tobacco's (NCACT) announced today that former Deputy…

Outcome Capital Expands Its HealthTech and Digital Health Practice with the Addition of Karl Hess as Managing Director

3 years ago

BOSTON--(BUSINESS WIRE)--Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Karl Hess…

Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health

3 years ago

Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwideCHICAGO, IL / ACCESSWIRE / March…

NLS Pharmaceutics Announces Early Access Program (EAP) Allowing Patients with Idiopathic Hypersomnia to Receive Treatment with Mazindol ER

3 years ago

Named Patient Program (NPP) enables physicians to prescribe the Company's novel Mazindol Extended-Release (ER) formulation to patients who have failed…